articleTop 1% cited
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
The Lancet Infectious Diseases · 2017 · Vol. 18(3) · pp. 318–327
Evelina Tacconelli✉(University of Verona)Elena Carrara(University of Verona)Alessia SavoldiStephan Harbarth(World Health Organization)Marc Mendelson(University of Cape Town)Dominique L. Monnet(European Centre for Disease Prevention and Control)Céline Pulcini(Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est)Gunnar Kahlmeter(Växjö Kommun)Jan Kluytmans(University Medical Center Utrecht)Yehuda Carmeli(Tel Aviv University)Marc Ouellette(Canadian Institutes of Health Research)Kevin Outterson(Boston University)Jean B. Patel(Centers for Disease Control and Prevention)Marco CavaleriEdward Cox(United States Food and Drug Administration)Chris R Houchens(Biomedical Advanced Research and Development Authority)M. Lindsay Grayson(The University of Melbourne)Paul Hansen(University of Otago)Nalini Singh(Children's National)Ursula TheuretzbacherNicola Magrini(World Health Organization)Aaron O. AboderinSeif Al-AbriNordiah Awang JalilNur BenzonanaSanjay BhattacharyaAdrian BrinkFrancesco BurkertOtto CarsGiuseppe CornagliaOliver J. DyarAlex W. FriedrichAna Cristina GalesSumanth GandraChristian G. GiskeDebra A. GoffHerman GoossensThomas GottliebManuel Guzmán BlancoWaleria HryniewiczDeepthi KattulaTimothy JinksSouha S. KanjLawrence D. KerrMarie-Paule KiényYang Soo KimRoman S. KozlovJaime LabarcaRamanan LaxminarayanKarin LederLeonard LeiboviciGabriel Levy-HaraJasper LittmanSurbhi Malhotra‐KumarVikas ManchandaLorenzo MojaB NdoyeAngelo PanDavid L. PatersonMical Paul(University of Otago)Haibo QiuPilar Ramón-PardoJesús Rodríguez‐BañoMaurizio SanguinettiSharmila SenguptaMike SharlandMassinissa Si-MehandLynn L. SilverWonkeung SongMartin SteinbakkJens ThomsenGuy ThwaitesJ W van der MeerNguyễn Văn KínhSilvio VegaMaría Virginia VillegasAgnes Wechsler-FördösHeiman WertheimEvelyn WesangulaNeil WoodfordFidan O YilmazAnna Zorzet
Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPneumonia and Respiratory InfectionsAntibiotic resistanceAcinetobacter baumanniiEnterococcus faeciumAntibioticsMedicineTigecyclineAcinetobacterMicrobiologyBiologyBacteria
MeSH terms
Anti-Bacterial AgentsHumansTuberculosisWorld Health OrganizationDrug Resistance, Bacterial
Funding
- Public Health Agency of Canada
Citations
5,914
FWCI
205.52
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Frontiers in Microbiology · 2019 · 1,586 citations
The value of antimicrobial peptides in the age of resistance
The Lancet Infectious Diseases · 2020 · 1,072 citations
Phytochemical composition and antibacterial activities of Azadirachta indica (Neem): significance of traditional medicine in combating infectious diseases and antimicrobial resistance
Journal of Pharmacognosy and Phytochemistry · 2023 · 8 citations
Antibacterial activities of honey against Escherichia coli and Staphylococcus aureus: A potential treatment for bacterial infections and alternative to antibiotics
Journal of Pharmacognosy and Phytochemistry · 2023 · 12 citations
Pharmacotherapy of infectious diseases
The Pharma Innovation · 2019 · 1 citations
References
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
PLoS Medicine · 2016 · 1,539 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine · 2009 · 63,014 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.